DRD2 and type 2 diabetes mellitus: Bromocriptine-QR is a unique formulation of micronized bromocriptine mesylate, a potent sympatholytic, dopamine D2 receptor agonist that is approved for the treatment of type 2 diabetes (T2D) by the U.S. Food and Drug Administration [1,2].